Skip to main content

Myasthenia Gravis

  • Reference work entry
  • First Online:
Encyclopedia of Clinical Neuropsychology
  • 19 Accesses

Synonyms

Autoimmune disorders

Short Description or Definition

Myasthenia gravis (MG) is an uncommon autoimmune disorder of the neuromuscular junction (NMJ) resulting in skeletal muscle weakness. Disruption of the postsynaptic receptors on the muscle membranes is caused by antibodies to the acetylcholine receptors (AChR), which prevent adequate amounts of acetylcholine from reaching the receptors and thus inhibiting muscle action potential. Abnormalities of thymus are common in MG patients and present as hyperplasia (70%) or thymomas (20%) (Kothari 2004; Romi et al. 2005). MG is characterized by a decrease in ocular, facial, respiratory, pharyngeal, and limb muscle strength that is exacerbated by repeated use of those muscles and generally improves with rest. Symptoms, however, can also fluctuate without apparent reason, and the disease may go into remission spontaneously in 10–20% of all MG patients lasting for years (Thomann and Pandya 1995).

Categorization and Presentation

Romi et...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References and Readings

  • Berrih-Aknin, S., & Le Panse, R. (2014). Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms. Journal of Autoimmunity, 52, 90–100.

    Article  PubMed  Google Scholar 

  • Bershad, E. M., Feen, E. S., & Suarez, J. I. (2008). Myasthenia gravis crisis. Southern Medical Journal, 101, 63–69.

    Article  PubMed  Google Scholar 

  • Burns, T. M., Grouse, C. K., Wolfe, G. I., Conaway, M. R., & Sanders, D. B. (2011). The MG-QOL15 for following the health-related quality of life for patients with myasthenia gravis. Muscle & Nerve, 43, 14–18.

    Article  Google Scholar 

  • Conti-Fine, B. M., Milani, M., & Kaminski, H. J. (2006). Myasthenia gravis: Past, present, and future. Journal of Clinical Investigation, 116(11), 2843–2854.

    Article  PubMed  PubMed Central  Google Scholar 

  • Fisher, J., Parkinson, K., & Kothari, M. J. (2003). Self-reported depressive symptoms in myasthenia gravis. Journal of Clinical Neuromuscular Disease, 4, 105–108.

    Article  PubMed  Google Scholar 

  • Garcia-Carrasco, M., Escarcega, R. O., Fuentes-Alexandro, S., Riebeling, C., & Cervera, R. (2007). Therapeutic options in autoimmune myasthenia gravis. Autoimmunity Reviews, 6, 373–378.

    Article  PubMed  Google Scholar 

  • Gilchrist, J. M. (1998). Myasthenia gravis. Medical Update for Psychiatrists, 3, 113–118.

    Article  Google Scholar 

  • Grob, D., Arsura, E. L., Brunner, N. G., & Namba, T. (1987). The course of myasthenia gravis and therapies affecting outcome. Annals of the New York Academy of Sciences, 505, 472–499.

    Article  PubMed  Google Scholar 

  • Hampton, T. (2007). Novel therapies target myasthenia gravis. JAMA, 298(2), 163–164.

    Article  PubMed  Google Scholar 

  • Hughes, T. (2005). The early history of myasthenia gravis. Neuromuscular Disorders, 15, 878–886.

    Article  PubMed  Google Scholar 

  • Kothari, M. J. (2004). Myasthenia gravis. Journal of the American Osteopathic Association, 104, 377–384.

    PubMed  Google Scholar 

  • Mahadeva, B., Phillips II, L. H., & Juel, V. C. (2008). Autoimmune disorders of neuromuscular transmission. Seminars in Neurology, 28, 212–227.

    Article  PubMed  Google Scholar 

  • Ochs, C. W., Bradley, R. J., Katholi, C. R., Byl, N. N., Brown, V. M., Jones, L. L., et al. (1998). Symptoms of patients with myasthenia gravis receiving treatment. Journal of Medicine, 29, 1–12.

    PubMed  Google Scholar 

  • Oosterhuis, H. J. G. H. (1997). Myasthenia gravis. Groningen: Groningen Neurological Press.

    Google Scholar 

  • Paul, R. H., Cohen, R. A., Gilchrist, J. M., Aloia, M. S., & Goldstein, J. M. (2000a). Cognitive dysfunctions in individuals with myasthenia gravis. Journal of the Neurological Sciences, 179, 59–64.

    Article  PubMed  Google Scholar 

  • Paul, R. H., Cohen, R. A., Goldstein, J. M., & Gilchrist, J. M. (2000b). Fatigue and its impact on patients with myasthenia gravis. Muscle & Nerve, 23, 1402–1406.

    Article  Google Scholar 

  • Paul, R. H., Cohen, R. A., Zawacki, T., Gilchrist, J. M., & Aloia, M. S. (2001a). What we have learned about cognition in myasthenia gravis?: A review of methods and results. Neuroscience and Biobehavioral Reviews, 25, 75–81.

    Article  PubMed  Google Scholar 

  • Paul, R. H., Nash, J. M., Cohen, R. A., Gilchrist, J. M., & Goldstein, J. M. (2001b). Quality of life and well-being of patients with myasthenia gravis. Muscle & Nerve, 24, 512–516.

    Article  Google Scholar 

  • Phillips II, L. H. (2003). The epidemiology of myasthenia gravis. Annals of the New York Academy of Sciences, 998, 407–412.

    Article  PubMed  Google Scholar 

  • Pourmand, R. (1997). Myasthenia gravis. Disease-a-Month, 43, 65–109.

    Article  PubMed  Google Scholar 

  • Romi, F., Gilhus, N. E., & Aarli, J. A. (2005). Myasthenia gravis: Clinical, immunological, and therapeutic advances. Acta Neurologica Scandinavica, 111, 134–141.

    Article  PubMed  Google Scholar 

  • Sanders, D. B., & Howard Jr., J. F. (2004). Disorders of neuromuscular transmission. In W. G. Bradley, R. B. Daroff, G. M. Fenichel, et al. (Eds.), Neurology in clinical practice, the neurological disorders (pp. 2441–2461). Philadelphia: Butterworth Heinemann.

    Google Scholar 

  • Seybold, M. E. (1983). Myasthenia gravis: A clinical and basic science review. Journal of the American Medical Association, 11, 2516–2521.

    Article  Google Scholar 

  • Sitek, E. J., BiliÅ„ska, M. M., Wieczorek, D., & Nyka, W. M. (2009). Neuropsychological assessment in myasthenia gravis. Neurological Sciences, 30(1), 9–14.

    Article  PubMed  Google Scholar 

  • Stewart, S. B., Robertson, K. R., Johnson, K. M., & Howard Jr., J. F. (2007). The prevalence of depression in myasthenia gravis. Journal of Clinical Neuromuscular Disease, 8, 111–115.

    Article  Google Scholar 

  • Thomann, K. H., & Pandya, S. (1995). Myasthenia gravis: Pathophysiology, diagnosis, differential diagnosis and management. Clinical Eye and Vision Care, 7, 3–13.

    Article  Google Scholar 

  • Ybarra, M. I., Kummer, A., Frota, E. R. C., Oliveira, J. T. D., Gomez, R. S., & Teixeira, A. L. (2011). Psychiatric disorders in myasthenia gravis. Arquivos de Neuro-Psiquiatria, 69(2A), 176–179.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jane Austin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Austin, J., Leon, P.A. (2018). Myasthenia Gravis. In: Kreutzer, J.S., DeLuca, J., Caplan, B. (eds) Encyclopedia of Clinical Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-57111-9_565

Download citation

Publish with us

Policies and ethics